|
Sundial Growers Inc.
August 20, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Sundial Growers Inc. (“Sundial” or the “Company”) (Nasdaq: SNDL), a “craft pioneering cannabis” company.
|
|
Myriad Genetics, Inc.
August 16, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN).
|
|
Just Energy Group Inc.
August 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Just Energy Group Inc. (“Just Energy or the “Company”) (NYSE: JE). A complaint has been filed against the Company and certain executives. Investors who purchased Just Energy securities between November 9, 2017 and July 23, 2019, inclusive (the “Class Period”), may be affected.
|
|
GTT Communications, Inc.
August 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GTT Communications, Inc. (“GTT or the “Company”) (NYSE: GTT). A complaint has been filed against the Company and certain executives. Investors who purchased GTT common stock between February 26, 2018 and July 1, 2019, inclusive (the “Class Period”), may be affected.
|
|
International Flavors & Fragrances
August 6, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of International Flavors & Fragrances (“IFF” or the “Company”) (NYSE: IFF).
|
|
Pluralsight, Inc.
August 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Pluralsight, Inc. (“Pluralsight” or the “Company”) (Nasdaq: PS).
|
|
2U, Inc.
July 31, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of 2U, Inc. (“2U” or the “Company”) (Nasdaq: TWOU).
|
|
Capital One Financial Corp.
July 29, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Capital One Financial Corporation (“Capital One” or the “Company”) (NYSE: COF).
|
|
Eagle Bancorp, Inc.
July 26, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eagle Bancorp, Inc. (“Eagle Bancorp” or the “Company”) (NASDAQ: EGBN), a bank holding company for EagleBank, Inc. (“EagleBank”), which provides commercial and consumer banking services. A complaint has been filed against the Company and certain executives and/or directors. Investors that purchased Eagle Bancorp securities between March 2, 2015 and July 17, 2019, inclusive (the “Class Period”), may be affected.
|
|
Casa Systems, Inc.
July 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Casa Systems, Inc. (“Casa Systems” or the “Company”) (NASDAQ: CASA). A complaint has been filed against the Company, certain executives and/or directors, and the underwriters of the Company’s December 15, 2017 initial public offering (the “IPO”) for alleged securities law violations. Investors that purchased Casa Systems’ common stock in or traceable to the Company’s IPO may be affected.
|
|
Reckitt Benckiser Group PLC
July 1, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY). A complaint has been filed against the Company and certain executives and/or directors. Investors that purchased Reckitt American Depositary Shares (“ADSs”) between July 28, 2014 and April 9, 2019, inclusive (the “Class Period”), may be affected.
|
|
Omnicell, Inc.
July 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Omnicell, Inc. (“Omnicell” or the “Company”) (Nasdaq: OMCL).
|
|
Diebold Nixdorf, Incorporated
July 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Diebold Nixdorf, Incorporated (“Diebold” or the “Company”) (NYSE: DBD). A complaint has been filed against the Company and certain executives. Investors that purchased Diebold securities between May 4, 2017 and July 4, 2017, inclusive (the “Class Period”), may be affected.
|
|
Eros International Plc
July 10, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eros International Plc (“Eros” or the “Company”) (NYSE: EROS), a company that distributes Indian language films. A complaint has been filed against the Company and certain executives. Investors that purchased Eros securities between July 28, 2017 and June 5, 2019, inclusive (the “Class Period”), may be affected.
|
|
CannTrust Holdings Inc.
July 31, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) continues to investigate claims on behalf of investors who purchased shares of CannTrust Holdings Inc. (“CannTrust” or the “Company”) (NYSE: CTST; OTC: CNTTF).
|
|
Community Health Systems, Inc.
June 5, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). A complaint has been filed against the Company, its CEO and Chairman of the Board, as well as certain other executives. Investors that purchased Community Health securities between February 20, 2017 and February 27, 2018, inclusive (the “Class Period”), may be affected.
|
|
RCI Hospitality Holdings, Inc.
June 5, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ: RICK). A complaint has been filed against the Company and certain executives. Investors that purchased RCI securities between August 10, 2017 and May 10, 2019, inclusive (the “Class Period”), may be affected.
|
|
First American Financial Corp.
May 29, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of First American Financial Corp. (“First American” or the “Company”) (NYSE: FAF).
|
|
Apyx Medical
April 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Apyx Medical Corporation (“Apyx Medical” or the “Company”) (NASDAQ: APYX), a company developing J-Plasma technology, a plasma-based surgical product for cutting, coagulation and ablation of soft tissue. A complaint has been filed in the United States District Court for the Middle District of Florida against the Company and its Chief Executive Officer. Investors that acquired Apyx Medical securities between August 1, 2018 and April 1, 2019, inclusive (the “Class Period”), may be affected.
|
|
BrightView Holdings, Inc.
April 24, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of BrightView Holdings, Inc. (“BrightView” or the “Company”) (NYSE: BV).
|
|
Lyft, Inc.
April 18, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Lyft, Inc. (“Lyft” or “Company”) (NASDAQ: LYFT).
|
|
Fusion Connect, Inc.
April 18, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Fusion Connect, Inc. (“Fusion Connect” or the “Company”) (NASDAQ: FSNN). A complaint has been filed in the United States District Court for the Southern District of New York against the Company and certain executives. Investors who purchased Fusion Connect shares between August 14, 2018 and April 2, 2019, inclusive (the “Class Period”), may be affected.
|
